ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 28.6 TWD 1.78% Market Closed
Updated: May 18, 2024

ScinoPharm Taiwan Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ScinoPharm Taiwan Ltd
Operating Income Peer Comparison

Comparables:
Y
3705
4746
S
4119
1795
1720

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$314.5m
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
-14%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$929.6m
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$675m
CAGR 3-Years
189%
CAGR 5-Years
62%
CAGR 10-Years
N/A
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$160.3m
CAGR 3-Years
-47%
CAGR 5-Years
-21%
CAGR 10-Years
-2%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.4B
CAGR 3-Years
30%
CAGR 5-Years
40%
CAGR 10-Years
47%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.3B
CAGR 3-Years
20%
CAGR 5-Years
28%
CAGR 10-Years
18%

See Also

What is ScinoPharm Taiwan Ltd's Operating Income?
Operating Income
314.5m TWD

Based on the financial report for Dec 31, 2023, ScinoPharm Taiwan Ltd's Operating Income amounts to 314.5m TWD.

What is ScinoPharm Taiwan Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-14%

Over the last year, the Operating Income growth was -22%. The average annual Operating Income growth rates for ScinoPharm Taiwan Ltd have been -6% over the past three years , -11% over the past five years , and -14% over the past ten years .